Provided by Tiger Trade Technology Pte. Ltd.

Lantern Pharma Inc.

0.9401
+0.08009.30%
Volume:276.17K
Turnover:252.41K
Market Cap:14.04M
PE:-0.57
High:0.9700
Open:0.8800
Low:0.8600
Close:0.8601
52wk High:4.70
52wk Low:0.8375
Shares:14.94M
Float Shares:12.00M
Volume Ratio:0.71
T/O Rate:2.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6362
EPS(LYR):-1.5709
ROE:-400.92%
ROA:-74.29%
PB:-4.36
PE(LYR):-0.60

Loading ...

Mar 10, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 11, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jan 08, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 08, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jan 06, 2021

Major Issues Report

8-K - Current report
Oct 29, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2020

Major Issues Report

8-K - Current report
Aug 21, 2020

Major Issues Report

8-K - Current report
Jul 30, 2020

Major Issues Report

8-K - Current report
Jul 30, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 16, 2020

Major Issues Report

8-K - Current report
Jun 23, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 23, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 19, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 17, 2020

Major Issues Report

8-K - Current report